GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Samsung Biologics Co rises 4.09% in Friday's session

Published by Global Banking & Finance Review

Posted on October 16, 2026

1 min read
Add as preferred source on Google
207940.KS 1,298,000.00 +4.09% last traded price, 16 Oct 2026
Previous close
1,247,000.00
Market cap
KRW 60.1tn

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Samsung Biologics Co shares in South Korea last traded at 1,298,000 KRW, 4.09% above their previous close of 1,247,000 KRW on 16 October 2026. The health care company’s market value was $44.64bn.

Last traded price1,298,000.00 KRW
Previous close1,247,000.00 KRW
Change from the previous close+4.09%
Market value$44.64bn

Prices of Samsung Biologics Co (207940.KS), listed in South Korea, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 16 October 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 15 October 2026. Market value is converted to US dollars at the ECB reference rate. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. Source: Eulerpool. How we compile these reports.

Samsung Biologics Co — daily KRX:207940

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Samsung Biologics Co on TradingView ↗

Related Articles

More from Markets

Explore more articles in the Markets category